You are here: Industry Insights > Zydus Cadila

News List

Zydus Cadila gets US FDA nod for Liothyronine Sodium Tablets expresspharma
January 25, 2021
Zydus Cadila has received final approval from the USFDA to market Liothyronine Sodium Tablets USP, 5 meg, 25 meg, and 50 meg (US RLD: Cytomel Tablets).
Four more COVID-19 vaccines in pipeline: Health Secretary expresspharma
January 14, 2021
Zydus Cadila, Sputnik V, Biological E and Gennova are in advanced clinical trials in India, some of them likely to approach drug controller for EUA, said Bhushan.
Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D expresspharma
January 04, 2021
The company will now be initiating Phase III clinical trial in around 30,000 volunteer.
Zydus gets DCGI approval for Saroglitazar Mg to treat non-alcoholic fatty liver disease expresspharma
December 31, 2020
Saroglitazar Mg is already approved for the treatment of type-2 diabetes and NASH.
Modi visits key vaccine facilities as COVID-19 case load surges expresspharma
November 30, 2020
The companies are testing homegrown vaccine options, as well as working on trials of vaccines being developed overseas.
Zydus concludes Phase II trials of Pegylated Interferon alpha-2b for COVID-19, to begin Phase III trials expresspharma
November 13, 2020
In 19 out of 20 patients, a single 1 mcg/kg dose of the drug demonstrated viral clearance as assessed by RT-PCR and a significant improvement in clinical symptoms, informs the company.
Zydus Cadila files IND application for ZYIL1, NLRP3 inflammasome inhibitor expresspharma
November 05, 2020
Zydus announced that it has filed the IND application of ZYIL1, a novel oral small molecule NLRP3 inhibitor candidate. Following up on its initiatives to fight COVID 19 with diagnostics, vaccines and therapeutics, the company is now focussing on ...
Zydus Cadila receives tentative USFDA approval for Linagliptin Tablets expresspharma
October 30, 2020
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor to improve glycemic control in adults with Type 2 diabetes mellitus.
Zydus Cadila gets tentative US FDA approval for Dapagliflozin Tablets expresspharma
October 30, 2020
Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated to improve glycemic control in adults with type 2 diabetes mellitus.
Zydus Cadila receives final approval from USFDA for Albuterol Tablets expresspharma
October 26, 2020
Zydus Cadila has received final approval from the USFDA to market Albuterol Tablets (US RLD: Proventil Tablets) in the strengths of 2 mg and 4 mg. Albuterol is a bronchodilator.

Previous page 1 2 3 4 5 6 7 8 Next page